Aurora Cannabis Inc.
ACBNASDAQHealthcare● Active
$3.41
+$0.03(+0.89%)
Market Cap$201621720
P/E Ratio—
52W High$6.665
52W Low$3.07
Aurora Cannabis Inc. (ACB) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ACB · earnings · updated Jun 8, 2026
Latest Earnings
Q1 FY2026Report Date: Feb 4, 2026EPS Actual
$0.09
Est. $0.10 · -7.4%
Revenue
$0.07B
Est. $0.07B · +2.0%
Fiscal Period
Q1 FY2026
FY ends December
Report Date
Feb 4, 2026
After Market Close
▼ Miss EPS▲ Beat Revenue
ACB reports quarterly as a NASDAQ-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.07
Rev. $15.39B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.07
Rev. Est.$15.39B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q2 FY2026 | Jun 11, 2026 | -$0.07 | — | — | — | $0.05B | — |
| ▼ Q1 FY2026 | Feb 4, 2026 | $0.10 | $0.09 | -7.4% | $0.07B | $0.07B | +2.0% |
| ▲ Q4 FY2025 | Nov 5, 2025 | $0.03 | $0.09 | +200.0% | $0.06B | $0.09B | -28.4% |
| ▼ Q3 FY2025 | Aug 6, 2025 | $0.18 | -$0.19 | -205.6% | $0.06B | $0.09B | -30.9% |
| ▼ Q2 FY2025 | Jun 18, 2025 | $0.11 | $0.07 | -36.4% | $0.06B | $0.09B | -28.8% |
| ▲ Q1 FY2025 | Feb 5, 2025 | -$0.09 | $0.06 | +166.7% | $0.06B | $0.09B | -31.0% |
| ▲ Q4 FY2024 | Nov 6, 2024 | -$0.22 | $0.04 | +118.2% | $0.06B | $0.05B | +17.4% |
| ▲ Q3 FY2024 | Aug 7, 2024 | -$0.35 | -$0.11 | +68.6% | $0.06B | $0.06B | +7.9% |
Q2 FY2026
Jun 11, 2026
EPS Actual
—
EPS Est.
-$0.07
EPS Surpr.
—
Revenue
—
Q1 FY2026
Feb 4, 2026Miss
EPS Actual
$0.09
EPS Est.
$0.10
EPS Surpr.
-7.4%
Revenue
$0.07B
Q4 FY2025
Nov 5, 2025Beat
EPS Actual
$0.09
EPS Est.
$0.03
EPS Surpr.
+200.0%
Revenue
$0.06B
Q3 FY2025
Aug 6, 2025Miss
EPS Actual
-$0.19
EPS Est.
$0.18
EPS Surpr.
-205.6%
Revenue
$0.06B
Q2 FY2025
Jun 18, 2025Miss
EPS Actual
$0.07
EPS Est.
$0.11
EPS Surpr.
-36.4%
Revenue
$0.06B
Q1 FY2025
Feb 5, 2025Beat
EPS Actual
$0.06
EPS Est.
-$0.09
EPS Surpr.
+166.7%
Revenue
$0.06B
Q4 FY2024
Nov 6, 2024Beat
EPS Actual
$0.04
EPS Est.
-$0.22
EPS Surpr.
+118.2%
Revenue
$0.06B
Q3 FY2024
Aug 7, 2024Beat
EPS Actual
-$0.11
EPS Est.
-$0.35
EPS Surpr.
+68.6%
Revenue
$0.06B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2028 | $0.00 | $0.00 | $0.00 | 1 |
| Q4 FY2027 | $0.00 | $0.00 | $0.00 | 0 |
| Q3 FY2027 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2027 | $0.00 | $0.00 | $0.00 | 0 |
| Q1 FY2027 | $0.01 | $0.01 | $0.01 | 1 |
| Q4 FY2026 | $0.08 | $0.09 | $0.10 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2028 | $0.1B | $0.1B | $0.1B | 1 |
| Q4 FY2027 | $0.1B | $0.1B | $0.1B | 1 |
| Q3 FY2027 | $0.1B | $0.1B | $0.1B | 2 |
| Q2 FY2027 | $0.1B | $0.1B | $0.1B | 2 |
| Q1 FY2027 | $0.1B | $0.1B | $0.1B | 1 |
| Q4 FY2026 | $0.1B | $0.1B | $0.1B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q1 FY2026 | Feb 4, 2026 | -7.4% | $4.06 | $3.75 | -7.64% |
| ▲ Q4 FY2025 | Nov 5, 2025 | +200.0% | $4.54 | $4.46 | -1.76% |
| ▼ Q3 FY2025 | Aug 6, 2025 | -205.6% | $4.60 | $4.24 | -7.83% |
| ▼ Q2 FY2025 | Jun 18, 2025 | -36.4% | $5.88 | $4.68 | -20.41% |
| ▲ Q1 FY2025 | Feb 5, 2025 | +166.7% | $3.68 | $5.37 | +45.92% |
| ▲ Q4 FY2024 | Nov 6, 2024 | +118.2% | $6.11 | $5.12 | -16.20% |
| ▲ Q3 FY2024 | Aug 7, 2024 | +68.6% | $5.88 | $6.25 | +6.29% |
| ▲ Q2 FY2024 | Jun 20, 2024 | +161.1% | $5.72 | $5.52 | -3.50% |
Q1 FY2026-7.64%
Report Date
Feb 4, 2026
EPS Beat/Miss
-7.4%
Price Before
$4.06
Price After
$3.75
Q4 FY2025-1.76%
Report Date
Nov 5, 2025
EPS Beat/Miss
+200.0%
Price Before
$4.54
Price After
$4.46
Q3 FY2025-7.83%
Report Date
Aug 6, 2025
EPS Beat/Miss
-205.6%
Price Before
$4.60
Price After
$4.24
Q2 FY2025-20.41%
Report Date
Jun 18, 2025
EPS Beat/Miss
-36.4%
Price Before
$5.88
Price After
$4.68
Q1 FY2025+45.92%
Report Date
Feb 5, 2025
EPS Beat/Miss
+166.7%
Price Before
$3.68
Price After
$5.37
Q4 FY2024-16.20%
Report Date
Nov 6, 2024
EPS Beat/Miss
+118.2%
Price Before
$6.11
Price After
$5.12
Q3 FY2024+6.29%
Report Date
Aug 7, 2024
EPS Beat/Miss
+68.6%
Price Before
$5.88
Price After
$6.25
Q2 FY2024-3.50%
Report Date
Jun 20, 2024
EPS Beat/Miss
+161.1%
Price Before
$5.72
Price After
$5.52
Avg Beat Reaction+6.15%
Avg Miss Reaction-11.96%
Beat Rate5 / 8 quarters
Largest Move+45.92% (Q1 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ACB ends December
Aurora Cannabis Inc. (ACB) most recently reported earnings on February 4, 2026 for Q1 FY2026, posting EPS of $0.09 — missing the analyst consensus of $0.10 by -7.4%. The next ACB earnings date is expected around September 1, 2026.
Each quarter, investors track ACB earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ACB revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ACB's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ACB earnings · 5 questionsAurora Cannabis Inc.'s next earnings report is expected around September 1, 2026. ACB typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ACB historically reports after market close (AMC).
ACB earnings datewhen is ACB earningsACB next earnings datewhen does ACB report earningsACB earnings calendar
▸ Source: FMP · Aurora Cannabis Inc. SEC filings · US GAAP · Aurora Cannabis Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026